rs200287374
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_020066.5(FMN2):c.3174T>A(p.Leu1058Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0 ( 0 hom., cov: 1)
Exomes 𝑓: 0.00093 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
FMN2
NM_020066.5 synonymous
NM_020066.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -8.07
Publications
0 publications found
Genes affected
FMN2 (HGNC:14074): (formin 2) This gene is a member of the formin homology protein family. The encoded protein is thought to have essential roles in organization of the actin cytoskeleton and in cell polarity. This protein mediates the formation of an actin mesh that positions the spindle during oogenesis and also regulates the formation of actin filaments in the nucleus. This protein also forms a perinuclear actin/focal-adhesion system that regulates the shape and position of the nucleus during cell migration. Mutations in this gene have been associated with infertility and also with an autosomal recessive form of intellectual disability (MRT47). Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jul 2017]
FMN2 Gene-Disease associations (from GenCC):
- intellectual disability, autosomal recessive 47Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- autosomal recessive non-syndromic intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BP6
Variant 1-240207986-T-A is Benign according to our data. Variant chr1-240207986-T-A is described in ClinVar as Likely_benign. ClinVar VariationId is 435229.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-8.07 with no splicing effect.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020066.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FMN2 | TSL:5 MANE Select | c.3174T>A | p.Leu1058Leu | synonymous | Exon 5 of 18 | ENSP00000318884.9 | Q9NZ56-1 | ||
| FMN2 | c.188+994T>A | intron | N/A | ENSP00000505449.1 | A0A7P0T994 | ||||
| FMN2 | c.285+19724T>A | intron | N/A | ENSP00000505131.1 | A0A7P0Z432 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 3806Hom.: 0 Cov.: 1
GnomAD3 genomes
AF:
AC:
0
AN:
3806
Hom.:
Cov.:
1
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000807 AC: 11AN: 13632 AF XY: 0.000761 show subpopulations
GnomAD2 exomes
AF:
AC:
11
AN:
13632
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000935 AC: 108AN: 115560Hom.: 0 Cov.: 0 AF XY: 0.000950 AC XY: 60AN XY: 63138 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
108
AN:
115560
Hom.:
Cov.:
0
AF XY:
AC XY:
60
AN XY:
63138
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
5
AN:
2388
American (AMR)
AF:
AC:
0
AN:
4130
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
2162
East Asian (EAS)
AF:
AC:
3
AN:
3806
South Asian (SAS)
AF:
AC:
6
AN:
19478
European-Finnish (FIN)
AF:
AC:
4
AN:
14692
Middle Eastern (MID)
AF:
AC:
0
AN:
336
European-Non Finnish (NFE)
AF:
AC:
76
AN:
63372
Other (OTH)
AF:
AC:
10
AN:
5196
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.350
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 3806Hom.: 0 Cov.: 1 AF XY: 0.00 AC XY: 0AN XY: 2000
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
3806
Hom.:
Cov.:
1
AF XY:
AC XY:
0
AN XY:
2000
African (AFR)
AF:
AC:
0
AN:
576
American (AMR)
AF:
AC:
0
AN:
472
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
150
East Asian (EAS)
AF:
AC:
0
AN:
72
South Asian (SAS)
AF:
AC:
0
AN:
46
European-Finnish (FIN)
AF:
AC:
0
AN:
210
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
0
AN:
2210
Other (OTH)
AF:
AC:
0
AN:
60
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
FMN2-related disorder (1)
-
-
1
not specified (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.